👍🏻-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
Comment
Favorite

chiamvivian
2022-01-10

👍🏻

Novavax files for emergency use authorization of COVID-19 vaccine in South Africa

Novavax and Serum Institute of India Pvt. Ltd. (SII), announce a regulatory submission to the South

Novavax files for emergency use authorization of COVID-19 vaccine in South Africa

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment

Top
Latest

jimmylaw
·2022-01-10
comments
Reply
Like
Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":9006455236,"tweetId":"9006455236","gmtCreate":1641825974881,"gmtModify":1676533651348,"author":{"id":3585387105659739,"idStr":"3585387105659739","authorId":3585387105659739,"authorIdStr":"3585387105659739","name":"chiamvivian","avatar":"https://static.tigerbbs.com/e15ade855006a633183b8d976b5e3968","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>👍🏻</p></body></html>","htmlText":"<html><head></head><body><p>👍🏻</p></body></html>","text":"👍🏻","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9006455236","repostId":1126973509,"repostType":4,"repost":{"id":"1126973509","kind":"news","pubTimestamp":1641824052,"share":"https://www.laohu8.com/m/news/1126973509?lang=&edition=full","pubTime":"2022-01-10 22:14","market":"us","language":"en","title":"Novavax files for emergency use authorization of COVID-19 vaccine in South Africa","url":"https://stock-news.laohu8.com/highlight/detail?id=1126973509","media":"Seeking Alpha","summary":"Novavax  and Serum Institute of India Pvt. Ltd. (SII), announce a regulatory submission to the South","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/NVAX\">Novavax </a> and Serum Institute of India Pvt. Ltd. (SII), announce a regulatory submission to the South African Health Products Regulatory Agency (SAHPRA) for emergency use authorization (EUA) of Novavax&#39; protein-based COVID-19 vaccine candidate with Matrix-M adjuvant.</p><p>If authorized, the vaccine (known as NVX-CoV2373) will be manufactured and commercialized by SII in South Africa under the brand name Covovax.</p><p>The submission includes data from two Phase 3 clinical trials in U.S. and Mexico; and a trial in U.K. In both trials, the vaccine demonstrated high efficacy with a reassuring safety profile.</p><p>Novavax&#39; vaccine has received authorizations in over 170 countries, including conditional marketing authorization in the European Union and emergency use listing (EUL) from the WHO.</p><p>The company expects to submit a request for EUA for the vaccine in U.S. after one month in accordance with FDA guidance regarding submission of all EUA vaccines.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax files for emergency use authorization of COVID-19 vaccine in South Africa</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax files for emergency use authorization of COVID-19 vaccine in South Africa\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 22:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3786609-novavax-files-for-emergency-use-authorization-of-covid-19-vaccine-in-south-africa><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax  and Serum Institute of India Pvt. Ltd. (SII), announce a regulatory submission to the South African Health Products Regulatory Agency (SAHPRA) for emergency use authorization (EUA) of Novavax...</p>\n\n<a href=\"https://seekingalpha.com/news/3786609-novavax-files-for-emergency-use-authorization-of-covid-19-vaccine-in-south-africa\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3786609-novavax-files-for-emergency-use-authorization-of-covid-19-vaccine-in-south-africa","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126973509","content_text":"Novavax  and Serum Institute of India Pvt. Ltd. (SII), announce a regulatory submission to the South African Health Products Regulatory Agency (SAHPRA) for emergency use authorization (EUA) of Novavax' protein-based COVID-19 vaccine candidate with Matrix-M adjuvant.If authorized, the vaccine (known as NVX-CoV2373) will be manufactured and commercialized by SII in South Africa under the brand name Covovax.The submission includes data from two Phase 3 clinical trials in U.S. and Mexico; and a trial in U.K. In both trials, the vaccine demonstrated high efficacy with a reassuring safety profile.Novavax' vaccine has received authorizations in over 170 countries, including conditional marketing authorization in the European Union and emergency use listing (EUL) from the WHO.The company expects to submit a request for EUA for the vaccine in U.S. after one month in accordance with FDA guidance regarding submission of all EUA vaccines.","news_type":1},"isVote":1,"tweetType":1,"viewCount":775,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":100172211,"commentId":"100172211","gmtCreate":1641829482266,"gmtModify":1663242205548,"authorId":3570772304712620,"author":{"id":3570772304712620,"idStr":"3570772304712620","authorId":3570772304712620,"name":"jimmylaw","avatar":"https://static.tigerbbs.com/f6c847ae11f03f4682632e6fa4016040","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9006455236,"objectIdStr":"9006455236","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"comments","text":"comments","html":"comments","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}